Five‐year outcomes in liver transplant patients receiving everolimus with or without a calcineurin inhibitor: Results from the <scp>CERTITUDE</scp> study-Reference-Cited by-同舟云学术

Five‐year outcomes in liver transplant patients receiving everolimus with or without a calcineurin inhibitor: Results from the CERTITUDE study

Published:2022-09 Issue:11 Volume:42 Page:2513-2523
ISSN:1478-3223
Container-title:Liver International
language:en
Short-container-title:Liver International

Author:

Saliba Faouzi¹^ORCID,Duvoux Christophe²^ORCID,Dharancy Sébastien³^ORCID,Dumortier Jérôme⁴^ORCID,Calmus Yvon⁵^ORCID,Gugenheim Jean⁶^ORCID,Kamar Nassim⁷^ORCID,Salamé Ephrem⁸^ORCID,Neau‐Cransac Martine⁹^ORCID,Vanlemmens Claire¹⁰^ORCID,Durand François¹¹^ORCID,Pageaux Georges‐Philippe¹²^ORCID,Hardwigsen Jean¹³,Benkhatar Yasmina¹⁴,Derquenne François¹⁴,Conti Filomena⁶^ORCID

Affiliation:

1. AP‐HP, Hôpital Paul Brousse, Centre Hépato‐Biliaire, INSERM Unit 1193 Université Paris Saclay Villejuif France

2. AP‐HP‐Hopital henri Mondor, Université Paris Est Créteil France

3. Service Hépatologie‐Transplantation, Hôpital Huriez, CHRU Lille Lille France

4. Hospices civils de Lyon, Hôpital Edouard Herriot, Université Claude Bernard Lyon 1 Lyon France

5. APHP, Unité Médicale de Transplantation Hépatique, service d'hépato‐gastroentérologie, Hôpital Pitié Salpêtrière, Sorbonne Université, INSERM UMR S 938, Centre de recherche Saint‐Antoine (CRSA), Institute of Cardiometabolisme and Nutrition (ICAN) Paris France

6. Department of Digestive Surgery and Liver Transplantation Archet Hospital, Université Côte d'Azur, 151 Route de Saint‐Antoine de Ginestière, Nice France

7. Department of Nephrology and Organ Transplantation Toulouse University Hospital, Université Paul Sabatier Toulouse France

8. Service de Chirurgie Hépato‐Biliare et de Transplantation Hépatique, Hôpital Trousseau, Chambray les Tours, Tours France

9. Service de Chirurgie Hépatobiliaire et Transplantation Hépatique, Bâtiment Magellan, Hôpital Haut Lévèque Pessac France

10. Service Hépatologie et Soins Intensifs Digestifs, CHU Jean Minjoz Besançon Cedex France

11. AP‐HP Hôpital Beaujon Clichy France

12. Hôpital Saint Eloi Montpellier France

13. Hôpital la Timone Marseille France

14. Novartis Pharma SAS Rueil‐Malmaison France

Funder

Novartis

Publisher

Wiley

Subject

Hepatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/liv.15396

Reference15 articles.

1. Overview of immunosuppression in liver transplantation

2. Review on immunosuppression in liver transplantation

3. Calcineurin Inhibitors: Short-Term Friend, Long-Term Foe?

4. Is it time to give up with calcineurin inhibitors in kidney transplantation?

5. Efficacy and safety of everolimus treatment on liver transplant recipients: A meta‐analysis

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Current Use of Immunosuppression in Liver Transplantation;Surgical Clinics of North America;2024-02

2. Epidemiology of liver transplantation and post-LT complications in Germany: nationwide study (2005–2018);European Journal of Gastroenterology & Hepatology;2023-09-18

3. Combination of everolimus and low-dose tacrolimus controls histological liver allograft injury as sufficiently as high-dose tacrolimus;Frontiers in Transplantation;2023-04-20

4. State of the art and perspectives in liver transplantation;Hepatobiliary & Pancreatic Diseases International;2023-02

5. Long-Term Effects of Everolimus-Facilitated Tacrolimus Reduction in Living-Donor Liver Transplant Recipients with Hepatocellular Carcinoma;Annals of Transplantation;2022-11-14